Contrary, upregulation of ANP in NRVCMs has been demonstrated to reduce NFB-/TNF-induced immune responses [26, 42, 79, 109], highlighting the complex and often ambiguous role of RhoA-activation in the context of cardiac hypertrophy and immune responses. This evidence concerns the gene RHOA and cardiac hypertrophy.